46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2004-000482-35-LT (EUCTR)	08/11/2005	26/09/2005	A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflamm ...	A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflamm ...	Rheumatoid Arthritis	Product Name: Rosiglitazone Extended Release Tablets Product Code: BRL-049653 INN or Proposed INN: Rosi ...	GlaxoSmithKline Research & Development Ltd.	NULL	Not Recruiting			Female: yes Male: yes	96		United Kingdom;Lithuania
2	NCT00379600 (ClinicalTrials.gov)	November 2004	21/9/2006	The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis	A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Investigate the Anti-inflamm ...	Arthritis, Rheumatoid	Drug: rosiglitazone XR	GlaxoSmithKline	NULL	Completed	18 Years	N/A	Both	96	Phase 2	Lithuania;United Kingdom
3	EUCTR2004-000482-35-GB (EUCTR)	11/10/2004	08/02/2005	A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflamm ...	A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflamm ...	Rheumatoid Arthritis	Product Name: Rosiglitazone Extended Release Tablets Product Code: BRL-049653 INN or Proposed INN: Rosi ...	GlaxoSmithKline Research & Development Ltd.	NULL	Not Recruiting			Female: yes Male: yes	66	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Lithuania;United Kingdom

First Previous1Next Last